In this network meta-analysis, CTLA-4 inhibitors and cancer vaccines demonstrated a clear advantage in improving ORR, suggesting these modalities may elicit a stronger cytotoxic T-cell–mediated antitumor response capable of achieving radiographically detectable tumor shrinkage. Here, CTLA4 is linked to cancer.